RMD shares: your next growth investment?

raskmedia.com.au · 2026-09-10

The Resmed CDI (ASX:RMD) share price and QBE Insurance Group Ltd (ASX:QBE) share price are in focus in 2026. Here's how you could put a value on them.

TickrTrends take: RespiCare Medical Devices trades at a valuation that TickrTrends currently assesses as undervalued within the Healthcare sector, suggesting potential upside if the company can sustain or accelerate its growth trajectory. The market's apparent underpricing relative to fundamentals makes near-term catalysts particularly important to monitor, as positive earnings surprises or market share gains could narrow the valuation gap. Investors focused on value metrics should track whether the company's growth rate justifies higher multiples or if headwinds emerge that would validate the current discount to peers.

Read the full story at raskmedia.com.au →